Thrivent Financial for Lutherans
KYNB

Thrivent Financial for Lutherans’s Kyntra Bio KYNB Stock Holding History

Thrivent Financial for Lutherans’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,238
Closed -$1.04M – 2485
2023
Q1 		$1.04M Buy
+2,238
New +$1.18M ﹤0.01% 1767
2018
Q4 		– Sell
-628
Closed -$954K – 2001
2018
Q3 		$954K Sell
628
-129
-17% -$199K ﹤0.01% 1303
2018
Q2 		$1.19M Hold
757
– – ﹤0.01% 1160
2018
Q1 		$874K Buy
+757
New +$997K ﹤0.01% 1311

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thrivent Financial for Lutherans's KYNB Position: Q2 2023 in Review

Thrivent Financial for Lutherans sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 2,238 shares — an estimated $1.04M sold.

Thrivent Financial for Lutherans first reported a position in KYNB in Q1 2018 and held it in 4 quarters. The position peaked at $1.19M in Q2 2018. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Thrivent Financial for Lutherans reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 2,238 Kyntra Bio shares in Q2 2023, an estimated $1.04M.
  • Thrivent Financial for Lutherans first reported a position in Kyntra Bio in Q1 2018 and held it in 4 quarters.
  • Thrivent Financial for Lutherans's Kyntra Bio position peaked at $1.19M in Q2 2018.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2023, filed 14 Aug 2023.